Nagpur facility is the company's latest facility and manufactures oral solid products.
Moneycontrol News
Lupin share price gained more than 3 percent intraday Monday after the US health regulator inspected company's Nagpur facility with zero observations.
The pharma major announced the successful completion of an inspection carried out by the US Food and Drug Administration at its Nagpur facility.
The inspection concluded without any observations, the company said in its filing.
Nagpur facility is the company's latest facility and manufactures oral solid products.
At 11:58 hours IST, the stock price was quoting at Rs 764.70, up Rs 12.90, or 1.72 percent on the BSE.